Preclinical evaluation of injectable bone substitute materials

Matilde Bongio, Jeroen J J P van den Beucken, Sander C G Leeuwenburgh, John A. Jansen

Research output: Contribution to journalArticle

Abstract

Injectable bone substitutes (IBSs) represent an attractive class of ready-to-use biomaterials, both ceramic- and polymer-based, as they offer the potential benefit of minimally invasive surgery and optimal defect filling. Although in vitro assessments are the first step in the process of development, the safety and efficacy of an IBS strongly depend on validated preclinical research prior to clinical trials. However, the selection of a suitable preclinical model for performance evaluation of an IBS remains a challenge, as no gold standard exists to define the best animal model. In order to succeed in this attempt, we identified three stages of development, including (a) proof-of-principle, (b) predictive validity and (c) general scientific legitimacy, and the respective criteria that should be applied for such selection. The second part of this review provides an overview of commonly used animals for IBSs. Specifically, scientific papers published between January 1996 and March 2012 were retrieved that report the use of preclinical models for the evaluation of IBSs in situations requiring bone healing and bone augmentation. This review is meant not only to describe the currently available preclinical models for IBS application, but also to address critical considerations of such multi-factorial evaluation models (including animal species, strain, age, anatomical site, defect size and type of bone), which can be indicative but in most cases edge away from the human reality. Consequently, the ultimate goal is to guide researchers toward a more careful and meaningful interpretation of the results of experiments using animal models and their clinical applications.

Original languageEnglish
Pages (from-to)191-209
Number of pages19
JournalJournal of Tissue Engineering and Regenerative Medicine
Volume9
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Bone Substitutes
Bone
Injections
Animals
Animal Models
Bone and Bones
Illegitimacy
Defects
Minimally Invasive Surgical Procedures
Ceramics
Biocompatible Materials
Surgery
Polymers
Research Personnel
Clinical Trials
Safety
Biomaterials
Research

Keywords

  • Animal models
  • Bone augmentation
  • Bone defect
  • Bone substitutes
  • Ceramic-based biomaterials
  • Hydrogel-based biomaterials
  • Injectable
  • Preclinical studies

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Medicine(all)

Cite this

Bongio, M., van den Beucken, J. J. J. P., Leeuwenburgh, S. C. G., & Jansen, J. A. (2015). Preclinical evaluation of injectable bone substitute materials. Journal of Tissue Engineering and Regenerative Medicine, 9(3), 191-209. https://doi.org/10.1002/term.1637

Preclinical evaluation of injectable bone substitute materials. / Bongio, Matilde; van den Beucken, Jeroen J J P; Leeuwenburgh, Sander C G; Jansen, John A.

In: Journal of Tissue Engineering and Regenerative Medicine, Vol. 9, No. 3, 01.03.2015, p. 191-209.

Research output: Contribution to journalArticle

Bongio, M, van den Beucken, JJJP, Leeuwenburgh, SCG & Jansen, JA 2015, 'Preclinical evaluation of injectable bone substitute materials', Journal of Tissue Engineering and Regenerative Medicine, vol. 9, no. 3, pp. 191-209. https://doi.org/10.1002/term.1637
Bongio, Matilde ; van den Beucken, Jeroen J J P ; Leeuwenburgh, Sander C G ; Jansen, John A. / Preclinical evaluation of injectable bone substitute materials. In: Journal of Tissue Engineering and Regenerative Medicine. 2015 ; Vol. 9, No. 3. pp. 191-209.
@article{7b2691e13c4d4bc087f545ba4b9417f7,
title = "Preclinical evaluation of injectable bone substitute materials",
abstract = "Injectable bone substitutes (IBSs) represent an attractive class of ready-to-use biomaterials, both ceramic- and polymer-based, as they offer the potential benefit of minimally invasive surgery and optimal defect filling. Although in vitro assessments are the first step in the process of development, the safety and efficacy of an IBS strongly depend on validated preclinical research prior to clinical trials. However, the selection of a suitable preclinical model for performance evaluation of an IBS remains a challenge, as no gold standard exists to define the best animal model. In order to succeed in this attempt, we identified three stages of development, including (a) proof-of-principle, (b) predictive validity and (c) general scientific legitimacy, and the respective criteria that should be applied for such selection. The second part of this review provides an overview of commonly used animals for IBSs. Specifically, scientific papers published between January 1996 and March 2012 were retrieved that report the use of preclinical models for the evaluation of IBSs in situations requiring bone healing and bone augmentation. This review is meant not only to describe the currently available preclinical models for IBS application, but also to address critical considerations of such multi-factorial evaluation models (including animal species, strain, age, anatomical site, defect size and type of bone), which can be indicative but in most cases edge away from the human reality. Consequently, the ultimate goal is to guide researchers toward a more careful and meaningful interpretation of the results of experiments using animal models and their clinical applications.",
keywords = "Animal models, Bone augmentation, Bone defect, Bone substitutes, Ceramic-based biomaterials, Hydrogel-based biomaterials, Injectable, Preclinical studies",
author = "Matilde Bongio and {van den Beucken}, {Jeroen J J P} and Leeuwenburgh, {Sander C G} and Jansen, {John A.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/term.1637",
language = "English",
volume = "9",
pages = "191--209",
journal = "Journal of Tissue Engineering and Regenerative Medicine",
issn = "1932-6254",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Preclinical evaluation of injectable bone substitute materials

AU - Bongio, Matilde

AU - van den Beucken, Jeroen J J P

AU - Leeuwenburgh, Sander C G

AU - Jansen, John A.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Injectable bone substitutes (IBSs) represent an attractive class of ready-to-use biomaterials, both ceramic- and polymer-based, as they offer the potential benefit of minimally invasive surgery and optimal defect filling. Although in vitro assessments are the first step in the process of development, the safety and efficacy of an IBS strongly depend on validated preclinical research prior to clinical trials. However, the selection of a suitable preclinical model for performance evaluation of an IBS remains a challenge, as no gold standard exists to define the best animal model. In order to succeed in this attempt, we identified three stages of development, including (a) proof-of-principle, (b) predictive validity and (c) general scientific legitimacy, and the respective criteria that should be applied for such selection. The second part of this review provides an overview of commonly used animals for IBSs. Specifically, scientific papers published between January 1996 and March 2012 were retrieved that report the use of preclinical models for the evaluation of IBSs in situations requiring bone healing and bone augmentation. This review is meant not only to describe the currently available preclinical models for IBS application, but also to address critical considerations of such multi-factorial evaluation models (including animal species, strain, age, anatomical site, defect size and type of bone), which can be indicative but in most cases edge away from the human reality. Consequently, the ultimate goal is to guide researchers toward a more careful and meaningful interpretation of the results of experiments using animal models and their clinical applications.

AB - Injectable bone substitutes (IBSs) represent an attractive class of ready-to-use biomaterials, both ceramic- and polymer-based, as they offer the potential benefit of minimally invasive surgery and optimal defect filling. Although in vitro assessments are the first step in the process of development, the safety and efficacy of an IBS strongly depend on validated preclinical research prior to clinical trials. However, the selection of a suitable preclinical model for performance evaluation of an IBS remains a challenge, as no gold standard exists to define the best animal model. In order to succeed in this attempt, we identified three stages of development, including (a) proof-of-principle, (b) predictive validity and (c) general scientific legitimacy, and the respective criteria that should be applied for such selection. The second part of this review provides an overview of commonly used animals for IBSs. Specifically, scientific papers published between January 1996 and March 2012 were retrieved that report the use of preclinical models for the evaluation of IBSs in situations requiring bone healing and bone augmentation. This review is meant not only to describe the currently available preclinical models for IBS application, but also to address critical considerations of such multi-factorial evaluation models (including animal species, strain, age, anatomical site, defect size and type of bone), which can be indicative but in most cases edge away from the human reality. Consequently, the ultimate goal is to guide researchers toward a more careful and meaningful interpretation of the results of experiments using animal models and their clinical applications.

KW - Animal models

KW - Bone augmentation

KW - Bone defect

KW - Bone substitutes

KW - Ceramic-based biomaterials

KW - Hydrogel-based biomaterials

KW - Injectable

KW - Preclinical studies

UR - http://www.scopus.com/inward/record.url?scp=84925603861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925603861&partnerID=8YFLogxK

U2 - 10.1002/term.1637

DO - 10.1002/term.1637

M3 - Article

C2 - 23135814

AN - SCOPUS:84925603861

VL - 9

SP - 191

EP - 209

JO - Journal of Tissue Engineering and Regenerative Medicine

JF - Journal of Tissue Engineering and Regenerative Medicine

SN - 1932-6254

IS - 3

ER -